Kevin McElgunn
Corporate Officer/Principal at MYERS INDUSTRIES, INC.
Profile
Mr. Kevin McElgunn is Investment Director at Dow Chemical Corporate Venture Capital.
Mr. McElgunn joined Dow in 1985, progressing through a variety of sales, marketing and business management positions, primarily in Dow Specialty Chemicals businesses.
In 2002, he was named Business Director and General Manager, Biopharmaceutical Contract Manufacturing Services of DowPharma.
He joined the Dow Ventures group in 2004 as Platform Director, responsible for identifying, developing and implementing new business options aligned with Dow’s strategic interests.
In late 2005, he joined Dow’s Corporate Development group, identifying transformational enterprise-level opportunities.
McElgunn assumed his current role in late 2007.
Mr. McElgunn earned a Bachelors of Science degree in Chemical Engineering at Kansas State University in 1984, and an MBA at Northwood University in 1997.
Kevin McElgunn active positions
Companies | Position | Start |
---|---|---|
MYERS INDUSTRIES, INC. | Corporate Officer/Principal | 31/05/2022 |
Former positions of Kevin McElgunn
Companies | Position | End |
---|---|---|
Dow Chemical Corporate Venture Capital
Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Private Equity Investor | 28/02/2018 |
PFENEX INC. | Director/Board Member | - |
Training of Kevin McElgunn
Kansas State University | Undergraduate Degree |
Northwood University (Michigan) | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MYERS INDUSTRIES, INC. | Producer Manufacturing |
Private companies | 2 |
---|---|
Dow Chemical Corporate Venture Capital
Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Finance |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Kevin McElgunn